Table 2.
Relationship between cancer subtype and pathologic complete response (N, %).
Cancer Subtype | Non-pCR (n = 274, 82.8) |
pCR (N = 57, 17.2) |
Total (N = 331, 100) |
p-Value |
---|---|---|---|---|
HR(+), HER2(−) | 137 (93.8) | 9 (6.2) | 146 (100) | <0.001 |
HR(+), HER2(+) | 60 (75.9) | 19 (24.1) | 79 (100) | |
HR(−), HER2(+) | 36 (66.7) | 18 (33.3) | 54 (100) | |
Triple-negative | 41 (78.8) | 11 (21.2) | 52 (100) |
pCR: pathologic complete response; HR: hormone receptor; HER2: human epidermal growth factor receptor 2.